Chemicals companies are all over the map in terms of investment dollars.
Some are investing in new technologies while others are taking existing ones and turning them into new products.
This article is aimed at highlighting the major chemical companies in the US that are investing big bucks in new chemicals.
This list is by no means exhaustive and is based on the amount of money the company is spending on research and development, acquisitions and the like.
If you have any questions about the companies we mentioned in this article, feel free to ask in the comments below.
The top three chemicals companies in terms to the amount they are spending are:Johnson & Johnson (NYSE:JNJ)A joint venture between Johnson & ; Johnson & amp; and Dow Chemical (NYSE : DD) is building a new chemical processing plant in Illinois, and its new products are expected to be available in 2018.
It is one of the largest chemical companies with annual sales of more than $1.4 trillion.
The company is also in the process of building a manufacturing plant in China and plans to use that plant to make products for the US.
DuPont (NYSE .
D) The biggest chemical company in the world has spent millions of dollars on research projects to develop new chemicals and is also currently working on a major new plant in Indiana.
Du Pont is also building a $200 million plant in Mexico, and plans on using it to make materials for medical devices.
In the coming years, it is expected that DuPont will expand its plant in the United States, with its first new plants planned in California and Texas.
Monsanto (NYSE ) Monsanto is the largest agribusiness company in North America and its largest corporate shareholder is DuPont.
It has invested millions of times in research and developing new products that it hopes to sell in the next 10 years.
The new products from Monsanto are expected in 2018 to include insecticides, herbicides and other products.
Duvel Pharmaceuticals (NYSE ) Duvel is also investing millions of people to develop a new type of insulin.
Duval Pharmaceuticals also has a plant in Florida, and the company plans to make insulin products in the country for use by diabetic patients.
Pfizer (NYSE -PG) Pfizer is also the largest pharmaceutical company in America and one of its largest shareholders is Du Pont.
Pfizer also is building an artificial pancreas facility in Germany, and it plans to develop artificial pancreses in the U.S. as well.
The U.K. pharmaceutical giant is also a major investor in several startups.
Bayer (NYSE /NASDAQ:Bayer) Bayer is the second largest pharmaceutical manufacturer in the entire world.
The Bayer plant in Germany will be the largest plant in Europe and will be a major focus of the company in 2018 and beyond.
Bayer is also developing an insulin product for diabetic patients and is working to make it available to patients in the developing world.
Toluene (NYSE = TOLU) Toluene is the world’s largest producer of petroleum ethers.
It also manufactures a number of other products for a variety of uses.
The Toluenes main product is its epoxy resin.
The epoxy resins are used in many kinds of building products.
Pharmaceutical giant GlaxoSmithKline (NYSE ‘s:GSK) The drug giant is one part of Pfizer and Duvel.
The Pfizer plant in California is also under construction and is expected to begin production of the EpiPen in 2019.
The EpiPens are the first prescription drug to be marketed using this technology.
The first EpiPrices were launched in April 2018.
Pfizers and Duvel will be the two biggest pharmaceutical companies in Europe, and they will be in competition with each other for investors.
These three companies together have a combined value of more that $6.5 trillion.
They will be competing for investors who want to put their money into these three companies, which have been struggling for years to grow their business.
The bottom line is that all of these companies are investing a lot of money into new technologies and new products, which is why investors have seen such a dramatic rise in their stock prices in the last few years.